Literature DB >> 19860178

[Descriptive epidemiology of myeloid leukemia].

Keitaro Matsuo1, Hidemi Ito.   

Abstract

Epidemiologic information about specific types of leukemia in Japan is limited because limited data is available from population-based cancer registry. In this review, 1) history of International Classification of Diseases (ICD) about hematological malignancies, 2) current situation of population-based cancer registry for hematological malignancies, and 3) estimated incidence of acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) from selected population-based cancer registries (1993-2002 data from 15 registries) are presented. Estimated incidence of AML and CML in male and female in Japan are approximately half of those from SEER data in the United State. No clear change in incidence of AML/CML was observed between 1993 and 2002.

Entities:  

Mesh:

Year:  2009        PMID: 19860178

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

1.  Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia.

Authors:  Akiyoshi Takami; Shigeki Ohtake; Eriko Morishita; Yasushi Terasaki; Toshihiro Fukushima; Toshiro Kurokawa; Naomi Sugimori; Sadaya Matano; Kinya Ohata; Chizuru Saito; Masaki Yamaguchi; Kohei Hosokawa; Hirohito Yamazaki; Yukio Kondo; Shinji Nakao
Journal:  Int J Hematol       Date:  2012-08-15       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.